Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H22N4O3 |
Molecular Weight | 318.3709 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCN1C2=C(NC(=N2)[C@H]3CCC(=O)C3)C(=O)N(CCC)C1=O
InChI
InChIKey=RUHGOZFOVBMWOO-JTQLQIEISA-N
InChI=1S/C16H22N4O3/c1-3-7-19-14-12(15(22)20(8-4-2)16(19)23)17-13(18-14)10-5-6-11(21)9-10/h10H,3-9H2,1-2H3,(H,17,18)/t10-/m0/s1
Apaxifylline is an adenosine A1 receptor antagonist that was under investigation with Boehringer Ingelheim as a potential neuroprotective drug for the treatment of dementia. Apaxifylline was able to antagonize scopolamine-induced deficits in the rat in a memory task. A single oral application of apaxifylline 90 min before the rats received the noxious stimulus significantly attenuated the scopolamine-induced deficits observed during the retention trial of the rat in the passive avoidance paradigm. Apaxifylline treatment does not influence motility.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9203562
Curator's Comment: rat data
Single dose 1 mg/kg and 3 mg/kg
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1509
Created by
admin on Fri Dec 15 15:54:20 GMT 2023 , Edited by admin on Fri Dec 15 15:54:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
151581-23-6
Created by
admin on Fri Dec 15 15:54:20 GMT 2023 , Edited by admin on Fri Dec 15 15:54:20 GMT 2023
|
PRIMARY | |||
|
60949
Created by
admin on Fri Dec 15 15:54:20 GMT 2023 , Edited by admin on Fri Dec 15 15:54:20 GMT 2023
|
PRIMARY | |||
|
OG8HSX6N6H
Created by
admin on Fri Dec 15 15:54:20 GMT 2023 , Edited by admin on Fri Dec 15 15:54:20 GMT 2023
|
PRIMARY | |||
|
SUB05536MIG
Created by
admin on Fri Dec 15 15:54:20 GMT 2023 , Edited by admin on Fri Dec 15 15:54:20 GMT 2023
|
PRIMARY | |||
|
100000086976
Created by
admin on Fri Dec 15 15:54:20 GMT 2023 , Edited by admin on Fri Dec 15 15:54:20 GMT 2023
|
PRIMARY | |||
|
C81046
Created by
admin on Fri Dec 15 15:54:20 GMT 2023 , Edited by admin on Fri Dec 15 15:54:20 GMT 2023
|
PRIMARY | |||
|
7264
Created by
admin on Fri Dec 15 15:54:20 GMT 2023 , Edited by admin on Fri Dec 15 15:54:20 GMT 2023
|
PRIMARY | |||
|
GG-37
Created by
admin on Fri Dec 15 15:54:20 GMT 2023 , Edited by admin on Fri Dec 15 15:54:20 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104538
Created by
admin on Fri Dec 15 15:54:20 GMT 2023 , Edited by admin on Fri Dec 15 15:54:20 GMT 2023
|
PRIMARY |
ACTIVE MOIETY